FDA Approves Xigduo XR (dapagliflozin and metformin hydrochloride) for Type 2 Diabetes

WILMINGTON, Del., October 30, 2014 — AstraZeneca today announced that the U.S. Food and Drug Administration has approved once-daily Xigduo XR (dapagliflozin and metformin hydrochloride extended-release) for the treatment of adults with type 2…
Drugs.com – New Drug Approvals

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us